EAM
ROIV icon

Eventide Asset Management’s Roivant Sciences ROIV Stock Holding History

Eventide Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,143,938
Closed -$12.8M – 172
2023
Q4 		$12.8M Sell
1,143,938
-546,362
-32% -$5.32M 0.21% 111
2023
Q3 		$19.7M Hold
1,690,300
– – 0.35% 85
2023
Q2 		$17M Hold
1,690,300
– – 0.29% 93
2023
Q1 		$12.5M Hold
1,690,300
– – 0.23% 113
2022
Q4 		$13.5M Hold
1,690,300
– – 0.27% 97
2022
Q3 		$5.33M Hold
1,690,300
– – 0.1% 119
2022
Q2 		$6.74M Hold
1,690,300
– – 0.14% 109
2022
Q1 		$8.18M Buy
1,690,300
+990,300
+141% +$6.53M 0.13% 113
2021
Q4 		$6.7M Buy
+700,000
New +$5.82M 0.09% 123

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Eventide Asset Management's ROIV Position: Q1 2024 in Review

Eventide Asset Management sold out of Roivant Sciences (ROIV) in Q1 2024, closing a stake of 1,143,938 shares — an estimated $12.8M sold.

Eventide Asset Management first reported a position in ROIV in Q4 2021 and held it in 9 quarters. The position peaked at $19.7M in Q3 2023. 259 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.

  • Eventide Asset Management reported no remaining Roivant Sciences position as of Q1 2024 after selling out during the quarter.
  • Eventide Asset Management sold 1,143,938 Roivant Sciences shares in Q1 2024, an estimated $12.8M.
  • Eventide Asset Management first reported a position in Roivant Sciences in Q4 2021 and held it in 9 quarters.
  • Eventide Asset Management's Roivant Sciences position peaked at $19.7M in Q3 2023.
  • 259 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.